What I really need in a world of revolution. What I really want is a government solution, sang Peter Frampton in the song Solution. Likewise, this week in cardiology, we find ourselves searching for a solution to many unanswered questions, such as how can we prevent complications and reduce medical errors and at the same time cut costs?

Royal Philips Electronics and Corindus have established an alliance agreement to add Corindus robotic-assisted system for the minimally invasive treatment of obstructed coronary arteries to Philips interventional cardiology systems.

Bayer Healthcare has submitted rivaroxaban (Xarelto), an oral anticoagulant, for marketing approval to the Japanese Ministry of Health, Labor and Welfare. The drug is indicated for the prevention of stroke in atrial fibrillation patients.

GE Healthcare has released its latest PET/CT scanner, the Optima PET/CT 560, available in 8- and 16-slice configurations with automatic radiation dose reduction and modulation.

Medicare erroneously covered nearly 1.5 million outpatient ED imaging exams in 2008, resulting in $38 million of reimbursements for interpretations that were either incomplete or noncompliant with Centers for Medicare & Medicaid (CMS) rules, according to a Department of Health and Human Services report. In response, CMS vowed to fix most gaps, while disagreeing with one of the departments key recommendations.

LiveData has been identified for participation in the U.S. Armys Commercialization Pilot Program (CPP) to accelerate the transition of its data integration and display technology from development to implementation.

The FDA has granted St. Jude Medical approval for its Trifecta valve, a pericardial aortic tissue valve used in the replacement of diseased, damaged or malfunctioning aortic heart valves.

The European Union has granted InfraReDxs LipiScan IVUS Coronary Imaging System a nod of approval for its marketing throughout Europe.